Hyaluronidase-zzxf
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Hyaluronidase-zzxf, covering 2026-02-06 to 2026-02-06. Get the full timeline:
Most recent: Clinical Trial Update: Pertuzumab, Trastuzumab, Hyaluronidase-zzxf and Enzalutamide for Treatment of Metastatic Castration-Resistant Prostate Cancer [Phase 2]